Is Anastrozole Superior to Tamoxifen as First-Line Therapy for Advanced Breast Cancer?: In Reply

Article Tools SPECIAL DEPARTMENTS Article Tools OPTIONS & TOOLS Export Citation Track Citation Add To Favorites Rights & Permissions COMPANION ARTICLES No companion articles ARTICLE CITATION DOI: 10.1200/JCO.2001.19.9.2580 Journal of Clinical Oncology - published online before print September 21, 2016 PMID: 11331346 Is Anastrozole Superior to Tamoxifen as First-Line Therapy for Advanced Breast Cancer?: In Reply J. M. NabholtzxJ. M. NabholtzSearch for articles by this author , J. BonneterrexJ. BonneterreSearch for articles by this author , A. BuzdarxA. BuzdarSearch for articles by this author , J. F.R. RobertsonxJ. F.R. RobertsonSearch for articles by this author , B. ThürlimannxB. ThürlimannSearch for articles by this author , M. SteinbergxM. SteinbergSearch for articles by this author , A. WebsterxA. WebsterSearch for articles by this author , M. von EulerxM. von EulerSearch for articles by this author Show More University of California at Los Angeles, Los Angeles, CACenter Oscar Lambret, Lille, FranceM.D. Anderson Cancer Center, Houston, TXCity Hospital, Nottingham, United KingdomMedizinische Klinic C Kantonsspital, St Gallen, SwitzerlandAstraZeneca, Wilmington, DEAstraZeneca, Alderly Park, Cheshire, United Kingdom https://doi.org/10.1200/JCO.2001.19.9.2580 First Page Full Text PDF Figures and Tables © 2001 by American Society of Clinical Oncology